Hydrochlorothiazide
- Product NDC
- 67296-1682
- Requested package NDC
- 67296-1682-3
- 11-digit product format
- 672961682
- Labeler code
- 67296
- Product ID
- 67296-1682_b8df9dc5-96b4-e3c0-e053-2a95a90ab769
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA040412
- Marketing category
- ANDA
- Marketing start
- 2019-01-01
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 67296-1682 | 67296-1682-3 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040412-001 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | 2002-03-29 | ||
| A040412-002 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | 2002-03-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040412-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | 2002-03-29 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A040412-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | 2002-03-29 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 167f49f0-2d39-49a2-9f9e-1359a7c7ba3d | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals, INC. | 17362ff8-07bb-42c6-a100-8adb93be0348 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 9f9cd7a7-be95-4ea8-8247-eb7ecbd36936 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 0789baef-3424-43ab-a3fb-4908172da565 | 2026-07-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Redpharm Drug | 57436cfa-9b94-89bf-e063-6394a90aa264 | 2026-07-23 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 574d2679-c036-fa12-e063-6394a90aef33 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | d7214539-6c3d-466a-a474-6fde096fa182 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 03b7e52e-0003-47c3-af12-93ef00800b37 | 2026-07-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Lupin Pharmaceuticals, Inc. | ee1eaaf6-050b-48af-942b-5e3451edc164 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Sandoz Inc | f824b6ba-bd1c-41a8-8f6f-ad507b48f3e0 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | AvKARE | 569596a2-98f0-116a-e063-6294a90a3fa1 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Enalapril Maleate and Hydrochlorothiazide | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | Sun Pharmaceutical Industries, Inc. | 7cb92cf2-46f2-4379-937c-168d230e43a4 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | cb7b7315-0170-492c-803f-60a6e75e55da | 2026-07-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | f083c321-3170-4982-b5cd-d3fdff754857 | 2026-07-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 88aaa2a1-13be-4f56-ace6-66e899028007 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | a85f69f5-ba97-478d-e053-2a95a90a0a97 | 2026-07-06 | Warnings, Adverse reactions | 310798 197770 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Edenbridge Pharmaceuticals LLC. | 295532b5-65c8-40c3-8d27-cfd334d12802 | 2026-07-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | St. Mary's Medical Park Pharmacy | e1aa9682-b1ad-4a22-e053-2a95a90a0e2f | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Safecor Health LLC | 6fa96947-f4d8-4ca4-98fd-a2c123310d83 | 2026-06-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 3857ac53-0435-4d68-8066-c22291414889 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67296-1682-3 | 2024-08-05 | C162847 | 48780-1 | f386c649-e0f0-0266-e053-dadaa90a7c1a | Hydrochlorothiazide 25mg |
| 67296-1682-3 | 2023-01-30 | C162847 | 48780-1 | f386c649-e0f0-0266-e053-dadaa90a7c1a | Hydrochlorothiazide 25mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67296-1682-3 | Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67296-1682 | HYDROCHLOROTHIAZIDE TABLET [REDPHARM DRUG, INC.] | 4 | Legacy NDC, 1 package rows | 20240806_89a94550-d005-6102-e053-2a95a90afe14.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310798 | hydroCHLOROthiazide 25 MG Oral Tablet | PSN | 89a94550-d005-6102-e053-2a95a90afe14 | 4 |
| 310798 | hydrochlorothiazide 25 MG Oral Tablet | SCD | 89a94550-d005-6102-e053-2a95a90afe14 | 4 |
| 310798 | HCTZ 25 MG Oral Tablet | SY | 89a94550-d005-6102-e053-2a95a90afe14 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67296-1682-3 | 67296168203 | 30 TABLET in 1 BOTTLE (67296-1682-3) | 30 tablet | 2019-01-01 | 0000-00-00 | No | No | Current |